Scientific Publications and Publication Strategy

Xcenda's medical writers will help your team communicate your product's value messages through credible scientific publications. 

Xcenda exhibits a strong publication track record with well over 300 published manuscripts in peer-reviewed journals and more than 700 poster presentations and symposia at national conferences. We have developed publication strategies across multiple therapeutic areas, including infectious disease, cardiovascular/metabolic, CNS/neuropsychiatry, oncology, urology, gastrointestinal, and orphan disease states.

Our long history of publication planning, our highly trained clinical staff, and our expertise in both managed care and health economics makes us uniquely qualified as medical writers and publication strategists.  In several instances, we have served as a strategic partner to optimize effective messaging to the managed care audience.

Recent publication and educational planning engagements include multi-year relationships that have resulted in:

  • 10 to 15 manuscripts (per client/disease area) in targeted clinical, health economics, and managed care journals within a 2-year period
  • 15+ posters (per client/disease area) at targeted disease state and managed care conferences within a 2-year period
  • Xcenda's payer market research team conducted more than 100 symposia and advisory boards in conjunction with relevant payer-focused conferences
  • Xcenda partnered with 25 brands in commercialization phase (October 2008 to September 2009)

Why choose Xcenda as your essential partner for dossiers, scientific publications, and publications strategy?

In addition to publication planning, Xcenda often conducts research and develops subsequent publications to further support and enhance the ability to convey a product’s value proposition to payers. Xcenda’s clients benefit from quick access to payer decision makers from all key segments through Managed Care Network, an Xcenda Market Research collaboration. Using online surveys, live meetings, or one-on-one interviews, Xcenda conducts evidence and message testing to ensure our clients’ publications and dossiers resonate with payers. These capabilities are key differentiators for Xcenda and allow us to serve as a truly strategic partner to our clients.

How can we help?

What our clients are saying...

"I was a bit hesitant to submit this cost-effectiveness manuscript to the top journal within our therapuetic space. Today we received notification of acceptance.  Thank you -- it is truly amazing to be accepted with one minor comment at a top tier journal!"

Large pharmaceutical company